ECSP18014922A - Composiciones de insulina de rápida acción - Google Patents
Composiciones de insulina de rápida acciónInfo
- Publication number
- ECSP18014922A ECSP18014922A ECIEPI201814922A ECPI201814922A ECSP18014922A EC SP18014922 A ECSP18014922 A EC SP18014922A EC IEPI201814922 A ECIEPI201814922 A EC IEPI201814922A EC PI201814922 A ECPI201814922 A EC PI201814922A EC SP18014922 A ECSP18014922 A EC SP18014922A
- Authority
- EC
- Ecuador
- Prior art keywords
- fast
- acting insulin
- insulin compositions
- insulin analog
- insulin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Abstract
La presente invención se refiere a una composición farmacéutica de insulina humana o análogo de insulina que incluye citrato, treprostinilo y agentes estabilizantes, que tiene acción farmacocinética y farmacodinámica más rápida que las formulaciones comerciales de productos análogos de insulina existentes y que es estable para uso comercial.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562210469P | 2015-08-27 | 2015-08-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP18014922A true ECSP18014922A (es) | 2018-04-30 |
Family
ID=57003563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECIEPI201814922A ECSP18014922A (es) | 2015-08-27 | 2018-02-27 | Composiciones de insulina de rápida acción |
Country Status (39)
Country | Link |
---|---|
US (3) | US9901623B2 (es) |
EP (2) | EP3340966B1 (es) |
JP (2) | JP6359780B2 (es) |
KR (1) | KR102018998B1 (es) |
CN (1) | CN107920992B (es) |
AR (1) | AR105712A1 (es) |
AU (1) | AU2016310475B2 (es) |
BR (1) | BR112018001755A2 (es) |
CA (1) | CA2994427C (es) |
CL (1) | CL2018000503A1 (es) |
CO (1) | CO2018002026A2 (es) |
CR (1) | CR20180118A (es) |
DK (1) | DK3340966T3 (es) |
DO (1) | DOP2018000059A (es) |
EA (1) | EA033396B1 (es) |
EC (1) | ECSP18014922A (es) |
ES (1) | ES2928664T3 (es) |
FI (1) | FI3340966T3 (es) |
HR (1) | HRP20221367T1 (es) |
HU (1) | HUE060626T2 (es) |
IL (1) | IL256939B (es) |
JO (1) | JO3749B1 (es) |
LT (1) | LT3340966T (es) |
MA (1) | MA42701B1 (es) |
MD (1) | MD3340966T2 (es) |
MX (1) | MX2018002482A (es) |
MY (1) | MY195781A (es) |
NZ (1) | NZ739338A (es) |
PE (1) | PE20180782A1 (es) |
PH (1) | PH12018500422B1 (es) |
PL (1) | PL3340966T3 (es) |
PT (1) | PT3340966T (es) |
RS (1) | RS63731B1 (es) |
SV (1) | SV2018005643A (es) |
TN (1) | TN2018000056A1 (es) |
TW (1) | TWI614025B (es) |
UA (1) | UA120142C2 (es) |
WO (1) | WO2017034956A1 (es) |
ZA (1) | ZA201800511B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA034393B1 (ru) | 2012-11-13 | 2020-02-03 | Адосиа | Состав инсулина быстрого действия, содержащий замещенное анионное соединение |
AR102869A1 (es) * | 2014-12-16 | 2017-03-29 | Lilly Co Eli | Composiciones de insulina de rápida acción |
JO3749B1 (ar) * | 2015-08-27 | 2021-01-31 | Lilly Co Eli | تركيبات إنسولين سريعة المفعول |
GB201607918D0 (en) | 2016-05-06 | 2016-06-22 | Arecor Ltd | Novel formulations |
EA201992351A1 (ru) * | 2017-06-01 | 2020-03-26 | Эли Лилли Энд Компани | Быстродействующие композиции инсулина |
US11510967B2 (en) | 2017-09-08 | 2022-11-29 | Eli Lilly And Company | Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol |
US20210038506A1 (en) * | 2018-04-04 | 2021-02-11 | Arecor Limited | Medical infusion pump system for the delivery of an insulin compound |
WO2019193349A1 (en) * | 2018-04-04 | 2019-10-10 | Arecor Limited | Medical infusion pump system for the delivery of an insulin compound |
US20210113763A1 (en) * | 2018-04-04 | 2021-04-22 | Arecor Limited | Medical infusion pump system for the delivery of an insulin compound |
FR3083985A1 (fr) | 2018-07-23 | 2020-01-24 | Adocia | Dispositif pour injecter une solution d'insuline(s) |
WO2019243627A1 (fr) | 2018-06-23 | 2019-12-26 | Adocia | Dispositif pour injecter une solution d'insuline(s) |
FR3083984A1 (fr) | 2018-07-23 | 2020-01-24 | Adocia | Dispositif pour injecter une solution d'insuline(s) |
EA202190552A1 (ru) * | 2018-09-18 | 2021-06-18 | Эли Лилли Энд Компани | Эрбуминовая соль трепростинила |
EP3996679B1 (en) * | 2019-07-12 | 2023-09-06 | Novo Nordisk A/S | High concentration insulin formulation |
CN115697379A (zh) * | 2020-06-30 | 2023-02-03 | 江苏恒瑞医药股份有限公司 | 速效胰岛素组合物及其医药用途 |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2740953A1 (de) | 1977-09-12 | 1979-03-22 | Thera Ges Fuer Patente | Verwendung von prostaglandinen zur senkung des blutzuckerspiegels |
EP0018609B1 (de) | 1979-04-30 | 1983-09-21 | Hoechst Aktiengesellschaft | Gegen Denaturierung beständige, wässrige Protein-Lösungen, Verfahren zu ihrer Herstellung und ihre Verwendung |
ZA821243B (en) * | 1981-03-10 | 1983-01-26 | Novo Industri As | Stabilized insulin preparation and method for their production |
FI78616C (fi) | 1982-02-05 | 1989-09-11 | Novo Industri As | Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt. |
PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
DK503386D0 (da) * | 1986-10-20 | 1986-10-20 | Novo Industri As | Peptidpraeparater |
AU612141B2 (en) | 1987-02-25 | 1991-07-04 | Novo Nordisk A/S | Novel insulin derivatives |
JPH04502465A (ja) | 1988-12-23 | 1992-05-07 | ノボ ノルディスク アクティーゼルスカブ | ヒトインシュリン類似物質 |
US5716927A (en) | 1988-12-23 | 1998-02-10 | Novo Nordisk A/S | Insulin analogs having a modified B-chain |
US5474978A (en) | 1994-06-16 | 1995-12-12 | Eli Lilly And Company | Insulin analog formulations |
US5912014A (en) | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
US5866538A (en) | 1996-06-20 | 1999-02-02 | Novo Nordisk A/S | Insulin preparations containing NaCl |
AUPO066096A0 (en) | 1996-06-26 | 1996-07-18 | Peptide Delivery Systems Pty Ltd | Oral delivery of peptides |
JPH10251146A (ja) | 1997-03-11 | 1998-09-22 | Toray Ind Inc | 糖尿病性神経障害の治療方法 |
DE69924232D1 (de) * | 1998-01-09 | 2005-04-21 | Novo Nordisk As | Stabilisierte insulin-zubereitungen |
ATE220917T1 (de) | 1999-01-26 | 2002-08-15 | Lilly Co Eli | Monodisperse formulierungen, die hexamere acylierte insulinanaloge enthalten |
RU2300367C2 (ru) | 1999-11-15 | 2007-06-10 | Ханамарадди Т. ГАНГАЛ | Жидкий лечебный состав для внутривенного введения, содержащий декстрозу и инсулин |
US20020141946A1 (en) | 2000-12-29 | 2002-10-03 | Advanced Inhalation Research, Inc. | Particles for inhalation having rapid release properties |
DE10114178A1 (de) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität |
ES2360182T3 (es) | 2002-05-07 | 2011-06-01 | Novo Nordisk A/S | Formulaciones solubles que comprenden insulina monomérica e insulina acilada. |
DE10227232A1 (de) | 2002-06-18 | 2004-01-15 | Aventis Pharma Deutschland Gmbh | Saure Insulinzubereitungen mit verbesserter Stabilität |
US20050043391A1 (en) * | 2003-07-17 | 2005-02-24 | Fong Benson M. | Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome |
CN1917866B (zh) * | 2003-12-16 | 2010-12-15 | 联合治疗公司 | 曲前列环素或它的衍生物,或其药学上可接受的盐在制备治疗和预防缺血性损害的药物中的用途 |
US20080090753A1 (en) * | 2004-03-12 | 2008-04-17 | Biodel, Inc. | Rapid Acting Injectable Insulin Compositions |
PT2319500E (pt) | 2004-03-12 | 2013-01-23 | Biodel Inc | Composições de distribuição de fármacos de actuação rápida |
EP1744739B1 (en) * | 2004-04-12 | 2010-03-31 | United Therapeutics Corporation | Use of treprostinil to treat neuropathic diabetic foot ulcers |
EP2292653B1 (en) * | 2005-02-02 | 2014-05-21 | Novo Nordisk A/S | Novel insulin derivatives |
WO2006082204A1 (en) * | 2005-02-02 | 2006-08-10 | Novo Nordisk A/S | Insulin derivatives |
US20070086952A1 (en) | 2005-09-29 | 2007-04-19 | Biodel, Inc. | Rapid Acting and Prolonged Acting Inhalable Insulin Preparations |
US8084420B2 (en) | 2005-09-29 | 2011-12-27 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
AU2006294565A1 (en) * | 2005-09-30 | 2007-04-05 | Perlegen Sciences, Inc. | Methods and compositions for screening and treatment of disorders of blood glucose regulation |
DE102006047613A1 (de) * | 2006-10-07 | 2008-04-10 | Sanofi-Aventis Deutschland Gmbh | Peristaltische Mikropumpe mit wechselbarem Pumpenkopf |
DE102006047538A1 (de) * | 2006-10-07 | 2008-04-10 | Sanofi-Aventis Deutschland Gmbh | Medikamentendosiersystem mittels Mikropumpe |
ES2744384T3 (es) | 2007-06-13 | 2020-02-24 | Novo Nordisk As | Formulación farmacéutica que comprende un derivado de insulina |
WO2009026517A2 (en) * | 2007-08-22 | 2009-02-26 | Gilead Colorado, Inc. | Therapy for complications of diabetes |
TWI394580B (zh) | 2008-04-28 | 2013-05-01 | Halozyme Inc | 超快起作用胰島素組成物 |
TWI451876B (zh) * | 2008-06-13 | 2014-09-11 | Lilly Co Eli | 聚乙二醇化之離脯胰島素化合物 |
EP2328636B1 (en) | 2008-08-28 | 2013-06-12 | Medingo Ltd. | Device for enhanced subcutaneous insulin absorption |
US9060927B2 (en) | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake |
US20120094902A1 (en) | 2009-03-27 | 2012-04-19 | Adocia | Fast-acting insulin formulation |
FR2943538B1 (fr) | 2009-03-27 | 2011-05-20 | Adocia | Formulation a action rapide d'insuline recombinante humaine |
RU2533217C3 (ru) | 2009-06-26 | 2020-12-21 | Ново Нордиск А/С | Препарат, содержащий инсулин, никотинамид и аминокислоту |
ES2525748T3 (es) | 2009-11-13 | 2014-12-29 | Toray Industries, Inc. | Agente terapéutico o profiláctico para la diabetes |
CA2805031A1 (en) | 2010-07-07 | 2012-01-12 | Biodel, Inc. | Compositions and methods for modulating the pharmacokinetics and pharmacodynamics of insulin |
JP2014501239A (ja) | 2010-12-14 | 2014-01-20 | ノヴォ ノルディスク アー/エス | インスリン、ニコチンアミドおよびアミノ酸を含む製剤 |
US9993529B2 (en) | 2011-06-17 | 2018-06-12 | Halozyme, Inc. | Stable formulations of a hyaluronan-degrading enzyme |
AU2012271361B2 (en) | 2011-06-17 | 2017-03-02 | Halozyme, Inc. | Continuous subcutaneous insulin infusion methods with a hyaluronan degrading enzyme |
US20130231281A1 (en) | 2011-11-02 | 2013-09-05 | Adocia | Rapid acting insulin formulation comprising an oligosaccharide |
JP5912426B2 (ja) * | 2011-11-07 | 2016-04-27 | ヤマハ発動機株式会社 | リニアコンベア |
MX361727B (es) | 2011-12-30 | 2018-12-14 | Halozyme Inc | Variantes de polipeptido ph20, formulaciones y usos de las mismas. |
US9381247B2 (en) | 2012-04-16 | 2016-07-05 | Biodel Inc. | Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain |
US9399065B2 (en) | 2012-04-16 | 2016-07-26 | Biodel Inc. | Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin |
US20150174209A1 (en) | 2012-05-25 | 2015-06-25 | Amylin Pharmaceuticals. Llc | Insulin-pramlintide compositions and methods for making and using them |
US20150065423A1 (en) * | 2013-08-30 | 2015-03-05 | Perosphere, Inc. | Rapid acting injectable formulations |
KR102351111B1 (ko) | 2014-01-13 | 2022-01-14 | 써멀린 다이어비티즈, 엘엘씨 | 초속효성 인슐린 제형 및 약제학적 전달 시스템 |
WO2015120457A1 (en) * | 2014-02-10 | 2015-08-13 | Biodel Inc. | Stabilized ultra-rapid-acting insulin formulations |
JO3624B1 (ar) * | 2014-05-08 | 2020-08-27 | Lilly Co Eli | تركيبات إنسولين سريعة المفعول |
AR102869A1 (es) | 2014-12-16 | 2017-03-29 | Lilly Co Eli | Composiciones de insulina de rápida acción |
US20180221385A1 (en) | 2015-07-28 | 2018-08-09 | Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Sante Et | A pharmaceutical preparation for improving absorption and postprandial hypoglycemic action of insulin |
JO3749B1 (ar) * | 2015-08-27 | 2021-01-31 | Lilly Co Eli | تركيبات إنسولين سريعة المفعول |
-
2016
- 2016-08-14 JO JOP/2016/0183A patent/JO3749B1/ar active
- 2016-08-16 TW TW105126161A patent/TWI614025B/zh active
- 2016-08-16 AR ARP160102504A patent/AR105712A1/es unknown
- 2016-08-19 HR HRP20221367TT patent/HRP20221367T1/hr unknown
- 2016-08-19 CA CA2994427A patent/CA2994427C/en active Active
- 2016-08-19 KR KR1020187005546A patent/KR102018998B1/ko active IP Right Grant
- 2016-08-19 BR BR112018001755-8A patent/BR112018001755A2/pt active Search and Examination
- 2016-08-19 JP JP2017545409A patent/JP6359780B2/ja active Active
- 2016-08-19 EP EP16771021.9A patent/EP3340966B1/en active Active
- 2016-08-19 US US15/241,412 patent/US9901623B2/en active Active
- 2016-08-19 PL PL16771021.9T patent/PL3340966T3/pl unknown
- 2016-08-19 MA MA42701A patent/MA42701B1/fr unknown
- 2016-08-19 RS RS20221041A patent/RS63731B1/sr unknown
- 2016-08-19 DK DK16771021.9T patent/DK3340966T3/da active
- 2016-08-19 WO PCT/US2016/047723 patent/WO2017034956A1/en active Application Filing
- 2016-08-19 EA EA201890343A patent/EA033396B1/ru unknown
- 2016-08-19 LT LTEPPCT/US2016/047723T patent/LT3340966T/lt unknown
- 2016-08-19 AU AU2016310475A patent/AU2016310475B2/en active Active
- 2016-08-19 TN TNP/2018/000056A patent/TN2018000056A1/en unknown
- 2016-08-19 ES ES16771021T patent/ES2928664T3/es active Active
- 2016-08-19 MX MX2018002482A patent/MX2018002482A/es unknown
- 2016-08-19 HU HUE16771021A patent/HUE060626T2/hu unknown
- 2016-08-19 CR CR20180118A patent/CR20180118A/es unknown
- 2016-08-19 FI FIEP16771021.9T patent/FI3340966T3/fi active
- 2016-08-19 UA UAA201801732A patent/UA120142C2/uk unknown
- 2016-08-19 PE PE2018000246A patent/PE20180782A1/es unknown
- 2016-08-19 MD MDE20180654T patent/MD3340966T2/ro unknown
- 2016-08-19 NZ NZ739338A patent/NZ739338A/en unknown
- 2016-08-19 EP EP22200405.3A patent/EP4169505A1/en not_active Withdrawn
- 2016-08-19 PT PT167710219T patent/PT3340966T/pt unknown
- 2016-08-19 MY MYPI2018700714A patent/MY195781A/en unknown
- 2016-08-19 CN CN201680048530.0A patent/CN107920992B/zh active Active
-
2018
- 2018-01-11 US US15/868,272 patent/US10925931B2/en active Active
- 2018-01-15 IL IL25693918A patent/IL256939B/en active IP Right Grant
- 2018-01-24 ZA ZA2018/00511A patent/ZA201800511B/en unknown
- 2018-02-23 DO DO2018000059A patent/DOP2018000059A/es unknown
- 2018-02-23 CO CONC2018/0002026A patent/CO2018002026A2/es unknown
- 2018-02-26 CL CL2018000503A patent/CL2018000503A1/es unknown
- 2018-02-26 PH PH12018500422A patent/PH12018500422B1/en unknown
- 2018-02-27 SV SV2018005643A patent/SV2018005643A/es unknown
- 2018-02-27 EC ECIEPI201814922A patent/ECSP18014922A/es unknown
- 2018-06-20 JP JP2018117015A patent/JP6935364B2/ja active Active
-
2021
- 2021-02-19 US US17/180,100 patent/US20210169988A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP18014922A (es) | Composiciones de insulina de rápida acción | |
CO2017011535A2 (es) | Composiciones de ácido obeticólico y métodos de uso | |
EA201691911A1 (ru) | Быстродействующие композиции инсулина | |
ECSP21072161A (es) | Composiciones de liberación retardada de linaclotida | |
MX2016008978A (es) | Formulaciones farmaceuticas de analogos de insulina y/o derivados de insulina estabilizadas y que estan libres de glicerol. | |
DOP2016000253A (es) | Nuevos compuestos | |
BR112016028697A2 (pt) | artigos que fornecem fragrâncias de longa duração | |
BR112017007753A2 (pt) | uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico. | |
CO2017004382A2 (es) | Composiciones farmacéuticas que comprenden lobeglitazona para administración oral | |
CL2019003801A1 (es) | Nuevas formulaciones orales de belinostato. | |
BR112018001836A2 (pt) | preparação contendo octocrileno estável ao odor | |
ECSP19085451A (es) | Composiciones de insulina de rápida acción | |
CL2015001721A1 (es) | Una composicion para el cuidado oral que comprende: a) uno o mas compuestos de pirofosfato, b) una o mas gomas espesantes y c) una fuente de ion de metal; y su uso de uno o mas compuestos de pirofosfato con una o mas gomas espesantes para reducir o prevenir la separacion de fases. | |
MA39115B1 (fr) | Régulateurs de nrf2 | |
BR112015029693A8 (pt) | formulação farmacêutica de um inibidor de hif hidroxilase, forma de dosagem sólida compreendendo a referida formulação e método para inibir a fotodegradação de ácido |